tiprankstipranks
Trending News
More News >
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Income Statement

Compare
91 Followers

Bone Biologics Income Statement

Last quarter (Q3 2025), Bone Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Bone Biologics's net income was $-666.74K. See Bone Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.22M$ 9.43M$ 3.67M$ 1.10M$ 825.01K
Depreciation and Amortization
$ 4.22M$ 9.43M$ 0.00$ 0.00$ 0.00
EBITDA
$ 107.16K$ 479.57K$ -752.91K$ -805.58K$ -825.01K
Operating Income
$ -4.22M$ -9.43M$ -3.67M$ -1.10M$ -825.01K
Other Income/Expenses
$ 106.74K$ 479.57K$ 2.18M$ -507.61K$ -998.08K
Pretax Income
$ -4.11M$ -8.95M$ -1.48M$ -1.61M$ -1.82M
Net Income
$ -4.11M$ -8.95M$ -1.48M$ -1.61M$ -1.82M
Per Share Metrics
Basic EPS
$ -4.83$ -34.01$ -31.15$ -37.35$ -35.68
Diluted EPS
$ -4.83$ -34.01$ -31.20$ -37.35$ -35.68
Weighted Average Shares Outstanding
1.52M 263.14K 47.60K 43.00K 51.00K
Weighted Average Shares Outstanding (Diluted)
1.52M 263.14K 47.66K 43.13K 51.14K
Currency in USD

Bone Biologics Earnings and Revenue History